NCT06998225

Brief Summary

Food allergies are more common in children, especially in Western countries. Around 5 to 8% of children have at least one food allergy, compared to only 1-2% of adults. These allergies can really affect child's quality of life and create stress for the whole family. The most common foods that cause allergic reactions are cow's milk, egg, nuts, fish, and shellfish. Until now, the usual way to manage a food allergy has been to completely avoid the food. But this can be hard, limiting kids diets and puts them at risk of accidental exposure, and may even cause nutritional problems. Oral immunotherapy (OIT) has become and alternative treatment. It consists in giving very small amounts of the food allergen regularly to help the body get used to it. Some studies show this helps children build tolerance faster than just avoiding the food. But OIT also comes with risks, including allergic reactions during the treatment, some of which can be serious. Some research is focusing on a gentler and safer option: giving children baked milk or baked egg. When milk or egg is baked (for example, in muffins or cookies), the high heat changes the proteins, making them less likely to cause allergic reactions. The heat breaks the parts of the protein that the immune system usually reacts to, and mixing them with wheat flour makes them even less reactive. Interestingly, this doesn't work for every food, peanuts, for example, can actually become more allergenic when heated. But in the case of milk and egg, baking seems to be very helpful. Giving baked milk or egg to allergic children has shown some immune system changes similar to OIT, but in a safer and more natural way. This can make life a lot easier, not just for the kids, but also for their families since it broadens their diet, improves their nutrition, and reduces stress in social situations. Studies suggest that introducing baked milk and egg early on could also help kids become fully tolerant sooner. At Sant Joan de Déu Hospital in Barcelona, doctors have been using OIT for milk and egg allergies since 2006 in children over 5 years old. While the treatment has helped many, not all children become fully desensitized, and some still react to milk or egg occasionally. The success rate is around 70%, and it's often less effective in children with severe allergies, like those who have had anaphylaxis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
148

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2016

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
5.5 years until next milestone

First Submitted

Initial submission to the registry

May 19, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 31, 2025

Completed
Last Updated

June 3, 2025

Status Verified

May 1, 2025

Enrollment Period

2.5 years

First QC Date

May 19, 2025

Last Update Submit

May 31, 2025

Conditions

Keywords

baked food tolerance

Outcome Measures

Primary Outcomes (1)

  • 1. To evaluate proportion of children who develop tolerance to raw milk or cooked/raw egg at 12 months.

    Proportion of participants who achieve clinical tolerance to raw cow's milk or cooked/raw egg following 12 months of intervention. All participants underwent a controlled oral food challenge (OFC) in day's hospital. The intervention will be evaluated positively if the participant become tolerant. An increase in the reaction threshold dose relative to the initial OFC will also be considered favorable. If symptoms appear immediately, the patient will be considered allergic.

    12 months from enrollment

Secondary Outcomes (3)

  • Change in immunologic markers (IgE, IgG4, Tregs, BAT).

    12 months intervention

  • Rate of reactions during oral food challenges.

    12 months intervention

  • Changes in threshold dose triggering reactions.

    12 months intervention

Study Arms (4)

Dietary intervention with cow's milk or egg baked cookies low dose

ACTIVE COMPARATOR

Baked Group 1: consume a daily fixed low dose of baked milk (0.0375g of milk protein) or baked egg (0.11 g of egg protein).

Dietary Supplement: Dietary intervention using cookies containing milk or egg low dose.

Cow's milk or egg allergy control low dose

NO INTERVENTION

Control Group 1: strict avoidance diet, excluding all milk or egg (as appropriate) and any foods containing them.

Dietary intervention with cow's milk or egg baked cookies high dose

ACTIVE COMPARATOR

Baked Group 2: continue a daily high dose of baked milk (0.55 g of milk protein) or baked egg (1.1 g of egg protein).

Dietary Supplement: Dietary intervention with cow's milk or egg baked cookies high dose

Tolerance to baked cow's milk or egg.

NO INTERVENTION

Avoidance

Interventions

Baked Group 1: consumed a daily fixed low dose of baked milk or egg (0.0375 g of milk protein or 0.11 g of egg protein) for 6 months, followed by an additional increase at that time (0.075 g or 0.22 g).

Dietary intervention with cow's milk or egg baked cookies low dose

Baked Group 2: continued a daily high dose of baked milk (0.55 g of milk protein or 1.1g egg protein) for 6 months. An increase dose is given at that time (1.1g cow's milk or 2g egg protein).

Dietary intervention with cow's milk or egg baked cookies high dose

Eligibility Criteria

Age12 Months - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children with confirmed allergy to cow's milk or cooked egg

You may not qualify if:

  • Contraindication to epinephrine use
  • Ongoing consumption of baked milk or egg goods

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Barcelona

Esplugues de Llobregat, Barcelona, 08950, Spain

Location

Related Publications (6)

  • Muraro A, Roberts G, Clark A, Eigenmann PA, Halken S, Lack G, Moneret-Vautrin A, Niggemann B, Rance F; EAACI Task Force on Anaphylaxis in Children. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy. 2007 Aug;62(8):857-71. doi: 10.1111/j.1398-9995.2007.01421.x. Epub 2007 Jun 21.

  • Leonard SA, Caubet JC, Kim JS, Groetch M, Nowak-Wegrzyn A. Baked milk- and egg-containing diet in the management of milk and egg allergy. J Allergy Clin Immunol Pract. 2015 Jan-Feb;3(1):13-23; quiz 24. doi: 10.1016/j.jaip.2014.10.001.

  • Kim JS, Nowak-Wegrzyn A, Sicherer SH, Noone S, Moshier EL, Sampson HA. Dietary baked milk accelerates the resolution of cow's milk allergy in children. J Allergy Clin Immunol. 2011 Jul;128(1):125-131.e2. doi: 10.1016/j.jaci.2011.04.036. Epub 2011 May 23.

  • Lambert R, Grimshaw KEC, Ellis B, Jaitly J, Roberts G. Evidence that eating baked egg or milk influences egg or milk allergy resolution: a systematic review. Clin Exp Allergy. 2017 Jun;47(6):829-837. doi: 10.1111/cea.12940. Epub 2017 May 17.

  • Anagnostou A, Mack DP, Johannes S, Shaker M, Abrams EM, DeSanto K, Greenhawt M. The Safety and Efficacy of Baked Egg and Milk Dietary Advancement Therapy: A Systematic Review and Meta-Analysis. J Allergy Clin Immunol Pract. 2024 Sep;12(9):2468-2480. doi: 10.1016/j.jaip.2024.06.016. Epub 2024 Jun 18.

  • Warren CM, Jiang J, Gupta RS. Epidemiology and Burden of Food Allergy. Curr Allergy Asthma Rep. 2020 Feb 14;20(2):6. doi: 10.1007/s11882-020-0898-7.

MeSH Terms

Interventions

EggsDiet TherapyMilk

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesNutrition TherapyTherapeuticsBeveragesDairy Products

Study Officials

  • Montserrat Alvaro, PhD, MD

    Hospital Sant Joan de Deu

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2025

First Posted

May 31, 2025

Study Start

June 1, 2016

Primary Completion

December 1, 2018

Study Completion

December 1, 2019

Last Updated

June 3, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

The following individual participant data will be shared: demographic data (age, sex), clinical outcomes (primary and secondary endpoints), laboratory results, and adverse events. Data will be available beginning 6 months after publication and will remain accessible for 5 years. Data will be shared with qualified researchers affiliated with academic or healthcare institutions, for purposes of academic research or meta-analysis, and can be used for further analysis of the intervention's efficacy, safety profiling, or inclusion in systematic reviews. Study protocol, statistical analysis plan, and informed consent forms (in anonymized format) will also be made available. Requests should be submitted to the corresponding author by email. A data access agreement must be signed, and the research proposal will be reviewed by the study steering committee before approval is granted.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Data will be available beginning 6 months after publication
Access Criteria
Researchers affiliated with academic or healthcare institutions

Locations